CUNEO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 22.411
EU - Europa 6.370
AS - Asia 4.576
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 13
SA - Sud America 13
AF - Africa 4
Totale 33.400
Nazione #
US - Stati Uniti d'America 22.396
CN - Cina 2.537
UA - Ucraina 1.656
DE - Germania 1.302
TR - Turchia 1.168
IT - Italia 1.048
GB - Regno Unito 652
SG - Singapore 536
SE - Svezia 400
FI - Finlandia 383
PL - Polonia 362
FR - Francia 228
VN - Vietnam 134
RU - Federazione Russa 130
ID - Indonesia 90
CZ - Repubblica Ceca 68
BE - Belgio 60
HK - Hong Kong 39
IN - India 28
NL - Olanda 22
ES - Italia 12
IR - Iran 12
AU - Australia 11
EU - Europa 10
IE - Irlanda 10
BR - Brasile 9
JP - Giappone 9
RO - Romania 9
CA - Canada 8
AT - Austria 7
CH - Svizzera 6
KR - Corea 6
IL - Israele 5
MX - Messico 5
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
MK - Macedonia 3
BD - Bangladesh 2
BG - Bulgaria 2
BY - Bielorussia 2
CL - Cile 2
HU - Ungheria 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PH - Filippine 2
EE - Estonia 1
GT - Guatemala 1
HR - Croazia 1
LT - Lituania 1
MA - Marocco 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 33.400
Città #
Fairfield 3.015
Woodbridge 2.968
Houston 1.998
Jacksonville 1.857
Chandler 1.676
Ann Arbor 1.362
Ashburn 1.316
Seattle 1.156
Wilmington 1.125
Cambridge 976
Izmir 643
Nanjing 592
Beijing 567
Princeton 480
Warsaw 354
Singapore 326
San Diego 311
Boardman 307
Ferrara 267
New York 225
Milan 203
Shanghai 199
Shenyang 188
Nanchang 171
Dong Ket 132
Hebei 128
Bremen 115
Addison 113
Changsha 97
Tianjin 93
Jakarta 89
Falls Church 88
Jiaxing 87
Dearborn 83
Jinan 70
Mountain View 69
Redwood City 63
Zhengzhou 61
Brussels 57
Norwalk 55
London 53
Brno 47
San Mateo 46
Kunming 45
Ningbo 40
Hong Kong 37
Los Angeles 36
Orange 34
Guangzhou 33
Des Moines 28
Washington 28
Auburn Hills 27
Rome 27
Taizhou 25
Tappahannock 25
Verona 24
Augusta 22
Chicago 21
Hangzhou 21
Indiana 21
Munich 21
Changchun 20
Lappeenranta 19
Olomouc 19
Philadelphia 18
Bologna 17
Haikou 17
Lanzhou 17
Florence 16
Leawood 16
San Francisco 16
Helsinki 15
Redmond 15
Napoli 14
Hefei 13
San Jose 13
Kilburn 11
Lozzo Atestino 11
Parma 10
Bari 9
Amsterdam 8
Fuzhou 8
Monmouth Junction 8
Dublin 7
Hounslow 7
Modena 7
Mumbai 7
Voghera 7
Chiswick 6
Wuhan 6
Naples 5
Newark 5
Saint Louis 5
Siena 5
Taiyuan 5
Valenzano 5
Ardabil 4
Bolzano 4
Cabanillas Del Campo 4
Chengdu 4
Totale 24.746
Nome #
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 188
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation 185
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 179
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia. 175
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 166
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis 165
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 158
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 157
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 154
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 154
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 150
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 149
MORFOLOGIA E FISIOPATOLOGIA DEL SANGUE E DEGLI ORGANI EMOPOIETICI 148
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 145
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 144
Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML 140
5' region and exon 7 mutations of the TP53 gene in two cases of B-cell prolymphocytic leukemia. 138
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 137
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 135
Novel small deletions of the p53 gene in late stage B-cell chronic lymphocytic leukaemia 134
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 134
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 132
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype 132
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 130
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 129
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 129
Ibrutinib in the real world patient: Many lights and some shades 129
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 128
Minimal morphological criteria for defining bone marrow dysplasia: A basis for clinical implementation of WHO classification of myelodysplastic syndromes 128
Acute Human Herpesvirus-6A infection of human mesothelial cells modulates HLA molecules 128
Tryptase-positive mast cells predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia 128
Secondary chromosome changes in mantle cell lymphoma: cytogenetic and fluorescence in situ hybridization studies. 127
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 126
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 125
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 125
null 124
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 123
Waldenstrom macroglobulinemia 123
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 122
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs 121
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 121
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 119
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 119
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 119
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 119
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype 119
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 119
Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings. 119
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 119
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 118
Exercise training and endothelial progenitor cells in haemodialysis patients 118
null 118
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia. 117
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 116
A novel translocation t(1;7)(p36;q34) in three patients with acute myeloid leukaemia 115
Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome on behalf of the GIMEMA chronic lymphoproliferative diseases working group 115
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 115
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 115
Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: Comparison with metaphase banding analysis 114
Hepatosplenic T-cell lymphoma (HSTCL). 112
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 112
Cytogenetic and clinicobiological features of acute leukemia with stem cell phenotype: study of nine cases 111
A prospective survey of febrile events in hematological malignancies 111
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 111
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 111
Delirium in acute promyelocytic leukemia patients: two case reports. 111
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 110
A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma 110
Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients 109
Dendritic cells in acute promyelocytic leukaemia 109
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 109
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells. 108
An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients 108
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 108
Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents. 108
Myelofibrosis with Myeloid Metaplasia (MMM)/Idiopathic myelofibrosis/Agnogenic myeloid metaplasia 108
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia. 107
Minor myeloid component in Ph chromosome-positive acute lymphoblastic leukaemia: correlation with cytogenetic pattern and implication for poor response to therapy 106
Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol 106
Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13) PDGFRB-NDE1 fusion 106
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 106
[Use of 5-phosphodiesterase inhibitors in patients with LUTS secondary to BPH: our experience and review of the literature]. 106
null 106
Special cytological subtypes of acute myeloid leukaemias and myelodysplastic syndromes 106
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 106
Early CP CML, Nilotinib 400 mg Twice Daily Frontline: Beyond 3 Years, Results Remain Excellent and Stable (A GIMEMA CML Working Party Trial) 106
Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation 105
null 105
Cytogenetics in myelodysplastic syndromes: Old methods, new clues 105
Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of patients with early B-cell chronic lymphocytic leukaemia. 104
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 104
t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes: characterization of a new subset of T acute lymphoblastic leukaemia 104
Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features 103
Etiology of Febrile Episodes in Patients With Acute Myeloid Leukemia: Results From the Hema e-Chart Registry 103
Mucosa-associated lymphoid tissue (MALT) lymphoma. 102
Angiopoietin-2 Plasma Dosage Predicts Time to First Treatment (TTFT) and Overall Survival (OS) in Chronic Lymphocytic Leukemia. 102
Merkel-cell polyomavirus (MCPyV) is rarely associated to B-chronic lymphocytic leukemia (1 out of 50) samples and occurs late in the natural history of the disease 102
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 101
Therapy-related adult acute lymphoblastic leukemia with t(4;11)(q21;q23): MLL rearrangement, p53 mutation and multilineage involvement 101
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 101
Totale 12.247
Categoria #
all - tutte 149.070
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 17.374
Totale 166.444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.275 1.254 210 197 1.062 481 843 631 748 574 810 333 132
2020/20215.638 418 469 311 546 275 620 206 639 109 802 779 464
2021/20224.235 230 531 203 195 226 230 230 260 138 359 427 1.206
2022/20234.073 500 178 138 464 698 594 181 363 560 21 250 126
2023/20242.042 186 284 97 50 128 283 89 111 65 55 79 615
2024/2025301 301 0 0 0 0 0 0 0 0 0 0 0
Totale 34.084